Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation
NCT ID: NCT00835783
Last Updated: 2014-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
30 participants
OBSERVATIONAL
2008-11-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The results should allow us to confirm our primary hypothesis: "FDG-PET/CT is better than established methods to confirm or exclude the diagnosis of infection/inflammation".
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Positron Emission Tomography of Infection and Vasculitis
NCT01878721
A Comparison of Static and Dynamic PET/CT (HYPOTHESIS Generation Study)
NCT05110443
Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation
NCT03312712
CD8+ T-cell PET/CT Imaging in COVID-19 Patients
NCT04874818
Assessment of Investigational Positron Emission Tomography and Post-Processing Procedures Performed as Add-ons to Standard of Care Imaging
NCT03490812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Part project A FDG-PET/CT in patients with blood culture positive for staphylococcus aureus and unresolved origin of infection.
Part project B FDG-PET/CT in patients with fever of unknown origin.
Part project C FDG-PET/CT in patients suspected of vascular graft infection.
Additionally, we wish to establish an optimal imaging protocol (necessity of fasting, consequences of antibiotic therapy prior to imaging, and the need of contrast), interpretation criteria, and the value of standard uptake values (SUV).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FUO
Patients with fever of unknown origin undergoing FDG-PET/CT as part of work-up.
No interventions assigned to this group
BUO
Patients with bacteremia of unknown origin undergoing FDG-PET/CT as part of work-up.
No interventions assigned to this group
VGI
Patients with vascular graft infections undergoing FDG-PET/CT as part of work-up.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
• Blood culture positive for staphylococcus aureus and unresolved origin of infection.
Part project B
* Fever of unknown origin
* Referred for FDG-PET/CT at the Department of Nuclear Medicine, Odense University Hospital.
Part project C
* Suspected vascular graft infection
* Referred for FDG-PET/CT at the Department of Nuclear Medicine, Odense University Hospital.
Exclusion Criteria
* Patients less than 18 years of age
* Patients from other regions than the Region of Southern Denmark
* Patients who cannot cooperate to PET/CT scan.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Søren Hess, MD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Søren Hess, MD
Role: PRINCIPAL_INVESTIGATOR
Odense University Hospital, Dept. of Nuclear Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Odense University Hospital, Dept. of Nuclear Medicine
Odense, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
105-K20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.